Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata
- PMID: 9062402
- PMCID: PMC2063398
- DOI: 10.1038/bjc.1997.147
Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata
Abstract
The present paper describes two immunoconjugates consisting of an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (MAb), named Mint5, covalently linked to the type 1 ribosome-inactivating proteins (RIPs) ocymoidine (Ocy) and pyramidatine (Pyra) from Saponaria ocymoides and Vaccaria pyramidata respectively. Both antibody and toxins are shown to retain their respective biological properties upon chemical conjugation. The immunoconjugates exert specific inhibition of EGFR expressing target cell proliferation and protein synthesis in in vitro assays and also inhibit the growth of grafted human tumour cells in nude mice.
Similar articles
-
Ribosome-inactivating proteins (RNA N-glycosidases) from the seeds of Saponaria ocymoides and Vaccaria pyramidata.Eur J Biochem. 1995 Mar 15;228(3):935-40. doi: 10.1111/j.1432-1033.1995.tb20343.x. Eur J Biochem. 1995. PMID: 7737197
-
Toxin-targeted design for anticancer therapy. II: Preparation and biological comparison of different chemically linked gelonin-antibody conjugates.J Pharm Sci. 1993 Jul;82(7):699-704. doi: 10.1002/jps.2600820706. J Pharm Sci. 1993. PMID: 8360843
-
Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.Br J Cancer. 1995 Dec;72(6):1373-9. doi: 10.1038/bjc.1995.517. Br J Cancer. 1995. PMID: 8519647 Free PMC article.
-
Immunotoxins containing single-chain ribosome-inactivating proteins.Cancer Treat Res. 1988;37:175-209. doi: 10.1007/978-1-4613-1083-9_12. Cancer Treat Res. 1988. PMID: 2908625 Review.
-
Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.Toxins (Basel). 2011 Jun;3(6):697-720. doi: 10.3390/toxins3060697. Epub 2011 Jun 22. Toxins (Basel). 2011. PMID: 22069735 Free PMC article. Review.
Cited by
-
Synergistic antitumor activity from two-stage delivery of targeted toxins and endosome-disrupting nanoparticles.Biomacromolecules. 2013 Apr 8;14(4):1093-102. doi: 10.1021/bm3019906. Epub 2013 Mar 11. Biomacromolecules. 2013. PMID: 23444913 Free PMC article.
-
Long term survival in a patient with recurrent malignant glioma treated with intratumoral infusion of an IL4-targeted toxin (NBI-3001).J Neurooncol. 2004 Jan;66(1-2):197-201. doi: 10.1023/b:neon.0000013478.27604.01. J Neurooncol. 2004. PMID: 15015787
-
Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.J Biol Chem. 2011 Feb 11;286(6):4165-72. doi: 10.1074/jbc.M110.186973. Epub 2010 Dec 7. J Biol Chem. 2011. PMID: 21138845 Free PMC article.
-
Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.J Neurooncol. 2003 Aug-Sep;64(1-2):125-37. doi: 10.1007/BF02700027. J Neurooncol. 2003. PMID: 12952293 Clinical Trial.
-
Sapovaccarin-S1 and -S2, Two Type I RIP Isoforms from the Seeds of Saponaria vaccaria L.Toxins (Basel). 2022 Jun 30;14(7):449. doi: 10.3390/toxins14070449. Toxins (Basel). 2022. PMID: 35878187 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous